21 May  2022

Once again showing the innovative character and the agility to develop precision PCR assays for the control of epidemic outbreaks, GPS ™ has already designed a kit of qPCR reagents for the rapid genetic detection of the Monkeypox. 



Please, click here for the Press Release. 



10 December  2021

GPS ™ has developed a qPCR kit for the specific detection of the SARS-CoV-2 Omicron variant. The assay allows monitoring the expansion of Omicron in the same PCR assay that is used for the diagnosis of CoVID-19.

Omicron variant



Please, click here for the Press Release. 


10 June  2021

New qPCR kit CoVID-19

CoVID-19 N / S MONODOSE dtec-RT-qPCR Duplex CE / IVD

 MONODSE format: ready-to-use tubes - Just add sample and run PCR as shown in this video!

No sample extraction / purification with GenoClean buffer (5 minutes)


• S gene target, maximum exclusivity (J. Appl. Microbiol. 130, 2-13. 2020) and 100% diagnostic specificity (ISCIII, Madrid; PHE, London)

• Target of the N gene, maximum sensitivity (CDC, Atlanta, 2020) 

• Transport at room temperature (dehydrated)  • Exogenous internal control 

• Fast-Cycling less than an hour  • Standard positive control


  Click the image for more info.


01 June  2021

Great success of the Network RISA (Researchers dedicated to Animal Health in Spain) with the conference: "African swine fever virus: A global disease demanding global solutions".


Clik the image to see the report   


21 April  2021

Dr. Martínez-Murcia presents trough IDIBE (Channel of the Institute for Research, Development and Innovation in Health Biotechnology of Elche) "SARS-Cov-2. Mutantes, variantes y vacunas. Las buenas y las malas noticias".



02 April  2021 

 2º Congreso Nacional Multidisciplinar CoVID-19 from 12 to 26 April, genetic PCR solutions™ with his Director Dr. Martínez-Murcia will present  New QPCR-Kit Specific Of SARS-CoV-2 British-Variant To Ascertain Real Incidence.

2021 08 26 13 52 48 2congresocovid



24 March  2021

Today, March 24, is the World Tuberculosis Day, the Network RISA (Researchers dedicated to Animal Health in Spain) where genetic PCR solutions™ is a member, has published a relevant report about this zoonotic disease.

MTBImage owned by IREC

Clik the image to see the report                                                                                                     



30 December  2020

The company genetic PCR solutions ™ develops an exclusive PCR kit for the new lineage B.1.1.7 of SARS-CoV2 emerging in the UK


Click the image to see the report and interview


03 September  2020

genetic PCR solutions ™ develops a qPCR kit to detect seasonal flu and differentiate it from CoVID-19 



 03 May  2020

genetic PCR solutions ™ report and interview with its founder and director, Dr. Martínez-Murcia. 


Click the image to see the report and interview


12 Abril  2020

genetic PCR solutions™  is working in a genetic test for the detection of coronaviruses to be used in health centers, the results could be obtained in  just 30 minutes. 


 Click the image to see the news



5 February,  2020


First CoVID-19 qPCR Kit Commercially Available


 Rapid Methods nCoV A

Click the image to see the news


10 February,  2020


Interview with CEO Prof. Dr. Martínez-Murcia - Insight into GPS™ CoVID-19 Ready-to-Use qPCR Kit







        Click the image to see the interview



  31 January,  2020

Interview at RTVE with Dr. Martinez-Murcia (Director of genetic PCR solutions™) about the recent design of qPCR kit fully specific for the detection of CoVID-19 (Severe acute respiratory syndrome coronavirus 2)






27 January,  2020

CoVID-19 (Severe acute respiratory syndrome coronavirus 2)- genetic PCR solutions™ 

genetic PCR solutions™ (GPS™), analysed the set of data and designed primers and probe fully specific for this new coronavirus. Please chek next link to see the GPS™ press release wich has been published internatonally.    

CoVID 19 CE LQ  

 Click here for CoVID-19 description, prices and content.



15 Friday, November 2019

Review of XXIV Simposium AVEDILA celebrated in Pamplona - November 2019



28 Monday, October 2019

XXIV Simposio AVEDILA  in Pamplona from 7 to 8 November 2019, genetic PCR solutions™ will present "Validación interna del panel GPS™ Mycoplasmas Contagious Agalactia dtec-qPCR siguiendo la norma UNE-EN ISO/IEC 17025:2005 para la detección en pequeños rumiantes.".



25 Tuesday, June 2019

28th Congress of Czechoslovak Society for Microbiology from 18 to 21 September 2019, Dr Martinez-Murcia as invited speaker will present at the plenary sessions "Phylogenetic analysis of the genus Listeria and innovations of the qPCR methods for L. monocytogenes detection in food".

Congreso Eslovaquia


06 Thursday, June 2019

GPS ™ participates as a collaborating entity in “AVEDILA 2019 Award For The Best Scientific Publication On Veterinary Laboratory Diagnosis”, convened by AVEDILA (Association Of Specialist Veterinarians In Laboratory Diagnosis).

cartel premio avedila2019



06 Wednesday, February 2019

ARREST-TB: Accurate, rapid, robust and economic diagnostic technologies for tuberculosis


The Spanish technology-based company Genetic Analysis Strategies SL, through its GPS™ brand, participates in the European project "ARREST-TB: Accurate, rapid, robust and economic diagnostic technologies for tuberculosis". The project brings together a consortium of academics from the University of Edinburgh, the Heriot Watt University, the University of Padua, together with the companies DestiNA Genómica and Optoi. The development of new technologies for the diagnosis of tuberculosis is projected to be evaluated in countries with a high prevalence for this infection, in close collaboration with the Central Institute of Tuberculosis Research, (Moscow, Russia), the National Institute for Tuberculosis Research (Chennai, India) and ShanMukha Innovations Pvt. Ltd.


Tuberculosis, a disease caused by bacteria of the species Mycobacterium tuberculosis, is a global threat to public health responsible of 1.3 million lives in 2016 and being the ninth leading cause of mortality in the world. The World Health Organization (WHO) has designed a route plan to follow with the aim of motivating collaborations that lead to the development of new diagnostic methods, allowing an improvement in the monitoring of patients. Tuberculosis, moreover, is not left out of the global growth of resistance to multiple antibiotics that has been detected in many pathogens. The rapid spread of these resistances is compromising the efficacy of antibiotics, including those of last resort. According to Dr Antonio Martinez-Murcia, professor at the Miguel Hernández University and director of GPS™, "as a result, drug resistance is considered to be the most accurate and imminent threat to the population".


GPS Team

The objective of the ARREST-TB project is the development of molecular probes and optical devices that enable effective action in the rapid diagnosis of Mycobacterium tuberculosis as well as the presence of its resistance to antibiotics. The development of trials that allow monitoring patients under treatment against tuberculosis and determine its evolution will be addressed.  


Know more about ARREST TB Project


17 Monday, September 2018

XXIII Simposio AVEDILA  in Granada from 15 to 16 November 2018, Dr Martinez-Murcia will present "Analysis of the exogenous and endogenous Feline leukemia virus sequences to design a robust qPCR test for Feline leukemia virus detection".



13 Thursday, September 2018

“Fast testing of ready-to-eat foods for pathogen detection by qPCR:  from samples to results in the same day.” Will be presented by Dr. Martinez-Murcia as a Keynote Speaker at The II Food Factor Conference in Malaga from 8th to 9th November 2018. FoodFactor II



11 Wednesday, April 2018

Annual Applied Microbiology Conference 2018 "Passport to Infection - Infections of Travel and Leisure" in Brighton from 9 to 11 July, where genetic PCR solutions™ will participate at the exhibition and presenting a poster.


12 Monday, March 2018  17:00

genetic PCR solutions™ will participate actively at the 20th Congress of the International Society for Human and Animal Mycology (ISHAM) in Amsterdam the next 30th to 4th of July 2018.

isham 2018

8 Thursday, March 2018 14:30

Dr. Martinez-Murcia will be part of the scientific committee and will present 'Internal validation of GPS™ CanAur dtec-qPCR Test following the UNE/EN ISO/IEC 17025:2005 for detection of emergent nosocomial Candida auris.' at VIII International Conference on Environmental, Industrial and Applied Microbiology "from 24 to 25 October in May (Spain).


21 Wednesday, February  2018 10:00

The PCR is becoming indispensable for all veterinary diagnostic laboratories. For this reason genetic pcr solutions™ has been registered as manufacturing company of animal health diagnostic reagents in the Ministry of Agriculture, Fisheries, Food and the Environment of Spain – MAPAMA





19 Wednesday, September  2017 18:00

genetic PCR solutions™ launches new Assay Kit designed for detection Candida auris by qPCR. 30 years of experience on microbial phylogenetic diversity and taxonomy, together with demonstrated skills in design and validation, ensures the best possible real-time PCR assay following thestrictest criteria .

Candida auris is an emerging fungus which grows as yeast and one of the few Candida species which can cause candidiasis in humans. Healthcare facilities in several countries have reported that C. auris has caused severe illness in hospitalized patients with weakened immune systems. It can cause invasive candidiasis, in which the blood stream is invaded, the central nervous system, kidneys, liver, bones, muscles, joints, spleen, or eyes. Some strains of C. auris are resistant to all three major classes of antifungal drugs. This type of multidrug resistance has not been seen before in other species of Candida. For this reason treatment is complicated, because C. auris is easily misidentified as other Candidaspecies.                                       CanAur2





 The laboratory Genetic PCR SolutionsTM (GPSTM) has developed a new, “highly inclusive” RT-qPCR kit for rapid genetic detection of Zika virus.

Last Friday 19th, laboratories GPSTM from the company Genetic Analysis Strategies S.L. has launched a new RT-qPCR kit that allows Zika virus genetic detection in any sample. The GPSTM kit is already available worldwide. The test is more inclusive, all reagents are stable at room Tª and served in a MONODOSE format that minimize handling.

Recently, Zika virus disease – an emerging viral disease transmitted by Aedes mosquito bites - has been spreading in the Americas and the Caribbean, following the first cases reported in Brazil. Arrival of the virus has been associated with a steep increase in the birth of babies with abnormally small heads and in cases of Guillain-Barré syndrome. A causal relationship between Zika virus infection and birth defects and neurological syndromes has not been established, but is strongly suspected. As the spread of Zika virus disease continues in the American Region, the risk of Zika-infected travellers entering Europe increases. Imported cases of Zika virus infection have been reported in several European countries.

Zika la Verdad

On 1st February 2016, the World Health Organisation (WHO) declared the Zika Virus outbreak to be a Public Health Emergency of International Concern.

A report dated on 29th January from the Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC, indicated: There is no commercially available test for Zika virus” and “serologic assays can be positive because of cross-reacting antibodies against related flaviviruses“.

In a few weeks, scientists from GPSTM have designed new specific primers and probes to detect the Zika virus, taking into account all new genomic sequences deposited to date at the public database (NCBI). As a consequence, the specificity of the test (in particular the inclusivity) has been improved in relation to these published to date in international journals. Calibration may be achieved with the standard known-copy number (included), to be used for estimative quantification.  The kit is available at several rxn-formats (F100, F300), but also in MONODOSE M60 and M120.